Nexstim Plc (5NX.F)

2.8200 -0.0300 (-1.05%) At close: 08:03AM CEST

Nexstim Plc

ElimAeenkatu 9 B
Helsinki 00510
Finland
358 9272 7170
https://www.nexstim.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 37

Description

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's navigated transcranial magnetic stimulation (nTMS) technology utilizes 3D navigation for providing accurate and personalized targeting of the TMS to the specific areas of the brain. It also offers Navigated Brain Therapy system, a navigated brain therapy system for the treatment of major depressive disorder (MDD) and chronic neuropathic pain; and Navigated Brain Stimulation (NBS) system, a navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily markets and sells its diagnostics systems to universities and teaching hospitals. Nexstim Plc was incorporated in 2000 and is headquartered in Helsinki, Finland.

Corporate governance

Nexstim Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.